STAAR Surgical Releases Shareholder Letter
STAAR Surgical Releases Update in New Shareholder Letter STAAR Surgical Company the global leader in phakic intraocular lenses (IOLs) and maker of the EVO family of Implantable Collamer® Lenses (EVO…
Category News
Read MoreSTAAR Surgical Releases Shareholder Letter
Delcath Systems Reports CHOPIN Clinical Trial Results Published in The Lancet Oncology
Delcath Systems Reports Publication of CHOPIN Clinical Trial Findings in The Lancet Oncology Delcath Systems, Inc. an interventional oncology company focused on the treatment of primary and metastatic liver cancers,…
EU Regulatory Reforms and Global Healthcare Innovation Take Center Stage @DIA Europe 2026
EU Regulatory Reforms and Global Healthcare Innovation to Be Central Focus at DIA Europe 2026 DIA, a global non-profit association of life sciences professionals, has announced that DIA Europe 2026…
National Grange Report Highlights Shift of Rural Health Funds to Urban Hospitals
National Grange Backs New Report Warning of Rural Health Funds Being Redirected to Urban Hospitals The National Grange has expressed strong support for the release of a comprehensive new analysis…
Cure Rare Disease and LGMD2L Foundation Partner Gene Therapy for Anoctamin 5 Disease
Strategic $7.65 Million Collaboration Aims to Accelerate Development of a Novel ANO5 Gene Replacement Therapy Toward Clinical Trials Cure Rare Disease (CRD), a nonprofit biotechnology organization dedicated to developing treatments…
MySpaLive Clarifies Texas Medical Aesthetics Law Amid Misleading 2026 Claims
MySpaLive’s Compliance and Training Framework As conversations continue across the medical aesthetics industry regarding claims that Texas has “closed a med spa loophole” in 2026, MySpaLive is issuing a detailed…
Biocytogen and IDEAYA Advance Innovative Cancer Therapy with First Dosing of IDE034
First Patient Dosed in Phase 1 Trial of IDE034, a Bispecific B7H3/PTK7 TOP1 ADC Why is the development of new cancer therapies so critical in today’s healthcare landscape? Biocytogen Pharmaceuticals…
Median Technologies to Present at TD Cowen’s 46th Annual Health Care Conference
AI-Powered Cancer Diagnosis Innovator to Share Latest Developments and Milestones Why is early cancer diagnosis still a critical challenge in the healthcare industry? Median Technologies, a global leader in AI-based…
Bayer Advances 225Ac-PSMA-Trillium for Metastatic Prostate Cancer
New Data Supports Next-Phase Development of Targeted Alpha Therapy Why is the treatment landscape for metastatic castration-resistant prostate cancer (mCRPC) so challenging? Despite significant advances, the prognosis for men with…
Natera’s Signatera MRD Advances Bladder Cancer Treatment and Patient Outcomes
New Data at ASCO GU Highlights Signatera’s Role in Bladder Preservation and Precision Medicine Why are precision medicine tools crucial for improving patient outcomes in genitourinary cancers? Natera, a global…
Ottawa Health Care Workers Rally Against Funding Cuts and Job Losses
CUPE Protests as 700 Nursing and PSW Jobs at Risk by 2027-28 Why are health care workers in Ottawa taking to the streets? The Canadian Union of Public Employees (CUPE)…
Texicare Expands Dental Coverage for Texas Small Businesses with Ameritas Partnership
Texicare Introduces Dental Coverage for Texas Businesses Through Ameritas Texicare, the health affiliate of Texas Mutual, is teaming up with Ameritas to enhance dental coverage options for small business employees…